Genelux Corporation

Last updated September 27, 2026

Organization details

Legal name
Genelux Corporation
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
GNLX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001231457

Board of directors

Chief executives

Thomas Zindrick ยท President and CEO
Since January 2023

Board connections

1 of this board's directors also sit on 2 other boards.

Network of Genelux Corporation's board connections Attovia Therapeutics Inc. Attovia Therapeutics I... NewAmsterdam Pharma Company N.V. NewAmsterdam Pharma Co... John W. Smither John W. Smither Genelux Corporation
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$221,407
22 sales by 6 insiders
Date Insider Transaction Shares Price Value
Aug 4, 2026 Cappello Joseph Officer (Chief Technical Officer) Open-market sale โˆ’653 $2.95 $1,924
Aug 4, 2026 Thomas Zindrick Officer (President and CEO) Open-market sale โˆ’3,023 $2.95 $8,905
Aug 4, 2026 Yu Yong Officer (Chief Scientific Officer) Open-market sale โˆ’653 $2.94 $1,922
Jul 1, 2026 John W. Smither Director Open-market sale โˆ’12,000 $2.91 $34,898
Jun 16, 2026 Groen Eric Officer (General Counsel) Grant or award +233,957 โ€” โ€”
Jun 16, 2026 Pulisic Matthew Officer (Chief Financial Officer) Grant or award +278,906 โ€” โ€”
Jun 16, 2026 Cappello Joseph Officer (Chief Technical Officer) Grant or award +174,841 โ€” โ€”
Jun 16, 2026 James L. Tyree Director Grant or award +28,409 โ€” โ€”
Jun 16, 2026 Thomas Zindrick Officer (President and CEO) Grant or award +730,601 โ€” โ€”
Jun 16, 2026 John Thomas Director Grant or award +28,409 โ€” โ€”
Jun 16, 2026 Mary Mirabelli Director Grant or award +28,409 โ€” โ€”
Jun 16, 2026 Yu Yong Officer (Chief Scientific Officer) Grant or award +119,318 โ€” โ€”
Jun 16, 2026 John W. Smither Director Grant or award +28,409 โ€” โ€”
Jun 3, 2026 Smalling Ralph Officer (Head of Regulatory) Open-market sale โˆ’192 $2.93 $563
Jun 1, 2026 John Thomas Director Open-market sale โˆ’10,000 $2.98 $29,800

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.